Nutex Health Valuation

NUTX Stock  USD 99.71  5.31  5.06%   
At this time, the firm appears to be undervalued. Nutex Health secures a last-minute Real Value of $136.5 per share. The latest price of the firm is $99.71. Our model forecasts the value of Nutex Health from analyzing the firm fundamentals such as Return On Equity of 1.02, current valuation of 897.69 M, and Profit Margin of 0.12 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Nutex Health's valuation include:
Price Book
2.2233
Enterprise Value
897.7 M
Enterprise Value Ebitda
2.4236
Price Sales
0.7187
Trailing PE
4.8663
Undervalued
Today
99.71
Please note that Nutex Health's price fluctuation is very steady at this time. Calculation of the real value of Nutex Health is based on 3 months time horizon. Increasing Nutex Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nutex Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nutex Stock. However, Nutex Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  99.71 Real  136.5 Target  250.0 Hype  101.58
The intrinsic value of Nutex Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nutex Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
136.50
Real Value
144.15
Upside
Estimating the potential upside or downside of Nutex Health helps investors to forecast how Nutex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nutex Health more accurately as focusing exclusively on Nutex Health's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
2.923.523.86
Details
Hype
Prediction
LowEstimatedHigh
93.93101.58109.23
Details
3 Analysts
Consensus
LowTarget PriceHigh
227.50250.00277.50
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nutex Health's intrinsic value based on its ongoing forecasts of Nutex Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nutex Health's closest peers.

Nutex Health Cash

52.62 Million

Nutex Health Total Value Analysis

Nutex Health is now anticipated to have valuation of 897.69 M with market capitalization of 705.14 M, debt of 340.3 M, and cash on hands of 47.6 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nutex Health fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
897.69 M
705.14 M
340.3 M
47.6 M

Nutex Health Investor Information

About 28.0% of the company outstanding shares are owned by corporate insiders. The book value of Nutex Health was now reported as 45.93. The company recorded earning per share (EPS) of 20.49. Nutex Health last dividend was issued on the 1st of November 2019. The entity had 1:10 split on the 3rd of July 2024. Nutex Health is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.

Nutex Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nutex Health has an asset utilization ratio of 73.24 percent. This suggests that the Company is making $0.73 for each dollar of assets. An increasing asset utilization means that Nutex Health is more efficient with each dollar of assets it utilizes for everyday operations.
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Nutex Health Profitability Analysis

Considering the key profitability indicators obtained from Nutex Health's historical financial statements, Nutex Health is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in March. Profitability indicators assess Nutex Health's ability to earn profits and add value for shareholders.
 
Net Income  
First Reported
2010-03-31
Previous Quarter
-17.7 M
Current Value
55.4 M
Quarterly Volatility
69.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Gross Profit is likely to rise to about 237 M in 2026. Pretax Profit Margin is likely to rise to 0.22 in 2026
For Nutex Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nutex Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nutex Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nutex Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nutex Health over time as well as its relative position and ranking within its peers.

Nutex Health Earnings per Share Projection vs Actual

By analyzing Nutex Health's earnings estimates, investors can diagnose different trends across Nutex Health's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Nutex Health is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Nutex Health is projected to generate 3.5175 in earnings per share on the 31st of December 2025. Nutex Health earnings estimates show analyst consensus about projected Nutex Health EPS (Earning Per Share). It derives the highest and the lowest estimates based on Nutex Health's historical volatility. Many public companies, such as Nutex Health, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Nutex Health Ownership Allocation

The market capitalization of Nutex Health is $705.14 Million. Nutex Health holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.

Nutex Health Profitability Analysis

The company reported the previous year's revenue of 479.95 M. Net Income was 95.27 M with profit before overhead, payroll, taxes, and interest of 560.39 M.

About Nutex Health Valuation

Our relative valuation model uses a comparative analysis of Nutex Health. We calculate exposure to Nutex Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nutex Health's related companies.
Last ReportedProjected for Next Year
Gross Profit225.7 M237 M
Pretax Profit Margin 0.21  0.22 
Operating Profit Margin 0.24  0.26 
Net Profit Margin 0.11  0.13 
Gross Profit Margin 0.37  0.39 

Nutex Health Current Valuation Indicators

Valuation refers to the process of determining the present value of Nutex Health and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Nutex we look at many different elements of the entity such as Nutex's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nutex Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nutex Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nutex Health's worth.

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.